List of Tables
Table 1. Preclinical Oncology CRO Market Trends
Table 2. Preclinical Oncology CRO Market Drivers & Opportunity
Table 3. Preclinical Oncology CRO Market Challenges
Table 4. Preclinical Oncology CRO Market Restraints
Table 5. Global Preclinical Oncology CRO Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Preclinical Oncology CRO Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Preclinical Oncology CRO Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Preclinical Oncology CRO Product Type
Table 9. Key Companies Time to Begin Mass Production of Preclinical Oncology CRO
Table 10. Global Preclinical Oncology CRO Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Oncology CRO as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Preclinical Oncology CRO Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Preclinical Oncology CRO Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Preclinical Oncology CRO Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Preclinical Oncology CRO Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Preclinical Oncology CRO Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Preclinical Oncology CRO Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Preclinical Oncology CRO Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Preclinical Oncology CRO Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Preclinical Oncology CRO Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Preclinical Oncology CRO Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Preclinical Oncology CRO Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Preclinical Oncology CRO Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Preclinical Oncology CRO Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Preclinical Oncology CRO Sales Value by Region (2019-2024) & (%)
Table 27. Global Preclinical Oncology CRO Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Preclinical Oncology CRO Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Preclinical Oncology CRO Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Preclinical Oncology CRO Sales Value, (2025-2030) & (US$ Million)
Table 31. Crown Bioscience Basic Information List
Table 32. Crown Bioscience Description and Business Overview
Table 33. Crown Bioscience Preclinical Oncology CRO Products, Services and Solutions
Table 34. Revenue (US$ Million) in Preclinical Oncology CRO Business of Crown Bioscience (2019-2024)
Table 35. Crown Bioscience Recent Developments
Table 36. Charles River Laboratory Basic Information List
Table 37. Charles River Laboratory Description and Business Overview
Table 38. Charles River Laboratory Preclinical Oncology CRO Products, Services and Solutions
Table 39. Revenue (US$ Million) in Preclinical Oncology CRO Business of Charles River Laboratory (2019-2024)
Table 40. Charles River Laboratory Recent Developments
Table 41. ICON Plc. Basic Information List
Table 42. ICON Plc. Description and Business Overview
Table 43. ICON Plc. Preclinical Oncology CRO Products, Services and Solutions
Table 44. Revenue (US$ Million) in Preclinical Oncology CRO Business of ICON Plc. (2019-2024)
Table 45. ICON Plc. Recent Developments
Table 46. Eurofins Scientific Basic Information List
Table 47. Eurofins Scientific Description and Business Overview
Table 48. Eurofins Scientific Preclinical Oncology CRO Products, Services and Solutions
Table 49. Revenue (US$ Million) in Preclinical Oncology CRO Business of Eurofins Scientific (2019-2024)
Table 50. Eurofins Scientific Recent Developments
Table 51. Taconic Biosciences Basic Information List
Table 52. Taconic Biosciences Description and Business Overview
Table 53. Taconic Biosciences Preclinical Oncology CRO Products, Services and Solutions
Table 54. Revenue (US$ Million) in Preclinical Oncology CRO Business of Taconic Biosciences (2019-2024)
Table 55. Taconic Biosciences Recent Developments
Table 56. Covance Basic Information List
Table 57. Covance Description and Business Overview
Table 58. Covance Preclinical Oncology CRO Products, Services and Solutions
Table 59. Revenue (US$ Million) in Preclinical Oncology CRO Business of Covance (2019-2024)
Table 60. Covance Recent Developments
Table 61. EVOTEC Basic Information List
Table 62. EVOTEC Description and Business Overview
Table 63. EVOTEC Preclinical Oncology CRO Products, Services and Solutions
Table 64. Revenue (US$ Million) in Preclinical Oncology CRO Business of EVOTEC (2019-2024)
Table 65. EVOTEC Recent Developments
Table 66. The Jackson Laboratory Basic Information List
Table 67. The Jackson Laboratory Description and Business Overview
Table 68. The Jackson Laboratory Preclinical Oncology CRO Products, Services and Solutions
Table 69. Revenue (US$ Million) in Preclinical Oncology CRO Business of The Jackson Laboratory (2019-2024)
Table 70. The Jackson Laboratory Recent Developments
Table 71. Wuxi AppTec. Basic Information List
Table 72. Wuxi AppTec. Description and Business Overview
Table 73. Wuxi AppTec. Preclinical Oncology CRO Products, Services and Solutions
Table 74. Revenue (US$ Million) in Preclinical Oncology CRO Business of Wuxi AppTec. (2019-2024)
Table 75. Wuxi AppTec. Recent Developments
Table 76. MI Bioresearch, Inc. Basic Information List
Table 77. MI Bioresearch, Inc. Description and Business Overview
Table 78. MI Bioresearch, Inc. Preclinical Oncology CRO Products, Services and Solutions
Table 79. Revenue (US$ Million) in Preclinical Oncology CRO Business of MI Bioresearch, Inc. (2019-2024)
Table 80. MI Bioresearch, Inc. Recent Developments
Table 81. Champion Oncology, Inc. Basic Information List
Table 82. Champion Oncology, Inc. Description and Business Overview
Table 83. Champion Oncology, Inc. Preclinical Oncology CRO Products, Services and Solutions
Table 84. Revenue (US$ Million) in Preclinical Oncology CRO Business of Champion Oncology, Inc. (2019-2024)
Table 85. Champion Oncology, Inc. Recent Developments
Table 86. Xentech Basic Information List
Table 87. Xentech Description and Business Overview
Table 88. Xentech Preclinical Oncology CRO Products, Services and Solutions
Table 89. Revenue (US$ Million) in Preclinical Oncology CRO Business of Xentech (2019-2024)
Table 90. Xentech Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Preclinical Oncology CRO Downstream Customers
Table 94. Preclinical Oncology CRO Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Preclinical Oncology CRO Product Picture
Figure 2. Global Preclinical Oncology CRO Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Preclinical Oncology CRO Sales Value (2019-2030) & (US$ Million)
Figure 4. Preclinical Oncology CRO Report Years Considered
Figure 5. Global Preclinical Oncology CRO Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Preclinical Oncology CRO Revenue in 2023
Figure 7. Preclinical Oncology CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Blood Cancer Picture
Figure 9. Solid Tumors Picture
Figure 10. Other Picture
Figure 11. Global Preclinical Oncology CRO Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Preclinical Oncology CRO Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of In Vitro
Figure 14. Product Picture of In Vivo
Figure 15. Global Preclinical Oncology CRO Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Preclinical Oncology CRO Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Preclinical Oncology CRO Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Preclinical Oncology CRO Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Preclinical Oncology CRO Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Preclinical Oncology CRO Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Preclinical Oncology CRO Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Preclinical Oncology CRO Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Preclinical Oncology CRO Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Preclinical Oncology CRO Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Preclinical Oncology CRO Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Preclinical Oncology CRO Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Preclinical Oncology CRO Sales Value (%), (2019-2030)
Figure 28. United States Preclinical Oncology CRO Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Preclinical Oncology CRO Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Preclinical Oncology CRO Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Preclinical Oncology CRO Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Preclinical Oncology CRO Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Preclinical Oncology CRO Sales Value by Application (%), 2023 VS 2030
Figure 34. China Preclinical Oncology CRO Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Preclinical Oncology CRO Sales Value by Type (%), 2023 VS 2030
Figure 36. China Preclinical Oncology CRO Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Preclinical Oncology CRO Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Preclinical Oncology CRO Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Preclinical Oncology CRO Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Preclinical Oncology CRO Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Preclinical Oncology CRO Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Preclinical Oncology CRO Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Preclinical Oncology CRO Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Preclinical Oncology CRO Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Preclinical Oncology CRO Sales Value by Application (%), 2023 VS 2030
Figure 46. India Preclinical Oncology CRO Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Preclinical Oncology CRO Sales Value by Type (%), 2023 VS 2030
Figure 48. India Preclinical Oncology CRO Sales Value by Application (%), 2023 VS 2030
Figure 49. Preclinical Oncology CRO Industrial Chain
Figure 50. Preclinical Oncology CRO Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
